Best lithospermic acid Onye nrụpụta na ụlọ ọrụ |Yongjian

lithospermic acid

Nkọwa dị mkpirikpi:

Aha nkịtị: Purple oxalic acid
English aha: lithospermic acid
Nọmba CAS: 28831-65-4
Arọ Molecular: 538.456
Njupụta: 1.6 ± 0.1 g / cm3
Ebe esi esi: 862.6 ± 65.0 ° C na 760 mmHg
Ụdị ihe omimi: C27H22O12
Ebe mgbaze: N/A
MSDS: N/A
Ebe Flash: 291.3 ± 27.8 Celsius C

Zitere anyị email

Nkọwa ngwaahịa

Mkpado ngwaahịa

Ngwa nke lithospermic acid

Lithospermic acid ((+) - lithospermic acid) bụ osisi sitere na polycyclic phenolic carboxylic acid nke dịpụrụ adịpụ na Salvia miltiorrhiza.Ọ nwere ọrụ antioxidant na hepatoprotective megide CCl4 butere nnukwu mmerụ ahụ na in vitro imeju.

Aha lithospermic acid

Aha Chinese: Purple oxalic acid
Aha Bekee:

(2S,3S) -4-[(E) -3-[(1R) -1-carboxy-2- (3,4-dihydroxyphenyl) ethoxy] -3-oxoprop-1-enyl] -2- (3, 4-dihydroxyphenyl) -7-hydroxy-2,3-dihydro-1-benzofuran-3-carboxylic acid.

Ọrụ ndu nke lithospermic acid

Nkọwa: lithospermic acid ((+) - lithospermic acid) bụ osisi sitere na polycyclic phenolic carboxylic acid nke dịpụrụ adịpụ na Salvia miltiorrhiza.Ọ nwere ọrụ antioxidant na hepatoprotective megide CCl4 butere nnukwu mmerụ ahụ na in vitro imeju.

Otu ndị emetụtara: ubi nyocha >> ndị ọzọ

Ụzọ mgbama > > ọzọ > > ọzọ

Ntụaka: [1].Chan KW, et al.Mmetụta mgbochi oxidative na hepatoprotective nke lithospermic acid megide carbon tetrachloride kpatara mmebi imeju oxidative na vitro na in vivo.Oncol Rep. 2015 Ọgọst; 34 (2): 673-80.

Njirimara physicochemical nke lithospermic acid

Njupụta: 1.6 ± 0.1 g / cm3

Ebe esi mmiri: 862.6 ± 65.0 ° C na 760 mmHg

Usoro ihe omimi: C27H22O12

Ibu ibu: 538.456

Ebe ọkụ: 291.3 ± 27.8 ° C

Ọnụ ọgụgụ ziri ezi: 538.111145

PSA: 211.28000

Ihe ndekọ: 1.45

Nrụgide Steam: 0.0 ± 0.3 mmHg na 25 Celsius

Ntụgharị ntụgharị: 1.745

Asụsụ Bekee nke Lithospermic acid

4-{(E) -2-[1-Carboxy-2- (3,4-dihydroxy-phenyl)-ethoxycarbonyl] -vinyl}-2- (3,4-dihydroxy-phenyl) -7-hydroxy-2, 3-dihydro-benzofuran-3-carboxylic acid

5-{(1E) -3-[1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxo-1-propen-1-yl}-2- (3,4-dihydroxyphenyl)-7 -hydroxy-2,3-dihydro-1-benzofuran-3-carboxylic acid

(2S,3S)-4-{(1E) -3-[(1R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxo-1-propen-1-yl}-2 (3,4-dihydroxyphenyl) -7-hydroxy-2,3-dihydro-1-benzofuran-3-carboxylic acid.

3-Benzofurancarboxylic acid, 4-[(1E) -3-[(1R) -1-carboxy-2- (3,4-dihydroxyphenyl) ethoxy] -3-oxo-1-propen-1-yl] -2- (3,4-dihydroxyphenyl) -2,3-dihydro-7-hydroxy-, (2S,3S)

Ụgwọ nke ụlọ ọrụ Jiangsu Yongjian Pharmaceutical Technology Co., Ltd

Jiangsu Yongjian Pharmaceutical Technology Co., Ltd., guzosie ike na March 2012, bụ a elu-tech Enterprise integrating R & D, mmepụta na ahịa.A na-etinyekarị aka na mmepụta, nhazi na mmepụta usoro mmepụta nke ihe ndị na-arụ ọrụ nke ngwaahịa ndị sitere n'okike, ihe ntụaka ọgwụ ndị China omenala na adịghị ọcha ọgwụ.Ụlọ ọrụ dị na China Pharmaceutical City, Taizhou City, Jiangsu Province, gụnyere 5000 square mita mmepụta isi na 2000 square mita R & D isi.Ọ na-eje ozi bụ isi ụlọ ọrụ nyocha sayensị, mahadum na ụlọ ọrụ mmepụta ihe decoction n'ofe mba ahụ.

Ka ọ dị ugbu a, anyị na-emepụta ihe karịrị 1500 iche iche nke eke compound reagents, na tụnyere na calibrated karịa 300 ụdị akwụkwọ ntụaka, nke nwere ike n'ụzọ zuru ezu izute kwa ụbọchị nnyocha mkpa nke isi sayensị nnyocha institutes, mahadum laboratories na decoction iberibe mmepụta ụlọ ọrụ.
Dabere na ụkpụrụ nke ezi okwukwe, ụlọ ọrụ na-atụ anya iji ezi obi na-akwado ndị ahịa anyị.Ebumnobi anyị bụ iji kwalite ọgwụ ọdịnala ndị China.